Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Shoulder InnovationsFRA:VB3 -5.08%18 Days Payable is 144.60 as of Jun. 2026, which is 19% below its 10-year median of 178.58. GuruFocus rates FRA:VB3 with a GF Score™ of 18/100. The stock has 3 warning signs investors should review. Among 795 Medical Devices & Instruments companies, Shoulder Innovations ranks better than 84.4% on this metric.
The historical rank and industry rank for Shoulder Innovations's Days Payable or its related term are showing as below:
FRA:VB3'
s Days Payable Range Over the Past 10 Years
Min: 170.9 Med: 178.58 Max: 225.5
Current: 191.21
During the past 3 years, Shoulder Innovations's highest Days Payable was 225.50. The lowest was 170.90. And the median was 178.58.
FRA:VB3's Days Payable is ranked better than 84.4% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 68.21
vs FRA:VB3: 191.21
Shoulder Innovations's Days Payable
declined
from Jun. 2025 (152.55) to Jun. 2026 (144.60).
It may suggest that Shoulder Innovationsaccelerated paying its suppliers.
The historical data trend for Shoulder Innovations's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:VB3 vs CLPT, PACB, DCTH: Days Payable Comparison
For the Medical Devices subindustry, Shoulder Innovations's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shoulder Innovations Days Payable vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Shoulder Innovations's Days Payable distribution charts can be found below:
* The bar in red indicates where Shoulder Innovations's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Shoulder Innovations's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shoulder Innovations (FRA:VB3) has a Days Payable of 144.60 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shoulder Innovations and its competitors. This is 19% below median its historical median of 178.58. Over the past decade, Shoulder Innovations' Days Payable has ranged from 170.90 to 225.50. According to the industry distribution chart, Shoulder Innovations ranks #124 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 15.6%.
Is Shoulder Innovations' Days Payable too high?
Shoulder Innovations' current Days Payable of 144.60 is 19% below median its 10-year median of 178.58. Over the past 10 years, this metric has ranged from a low of 170.90 to a high of 225.50. The Medical Devices & Instruments industry median Days Payable is 68.21. Shoulder Innovations' value of 144.60 is 112% above this industry median. Based on the distribution chart, Shoulder Innovations ranks #124 out of 795 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Shoulder Innovations has a GF Score™ of 18/100, reflecting its overall financial health beyond just this single metric.
How does Shoulder Innovations' Days Payable compare to CLPT and PACB?
According to the Medical Devices & Instruments industry distribution chart, Shoulder Innovations ranks #124 out of 795 companies for Days Payable. This places Shoulder Innovations in the top 16% of its industry — outperforming the majority of peers. The industry median Days Payable is 68.21. Shoulder Innovations' value of 144.60 is 112% above this benchmark. Historically, Shoulder Innovations' own Days Payable has ranged from 170.90 to 225.50 over the past decade. While the company's 10-year median is 178.58 vs. the industry median of 68.21, Shoulder Innovations has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Devices & Instruments company?
The median Days Payable among Medical Devices & Instruments companies is 68.21, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shoulder Innovations's current Days Payable of 144.60 is 112% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shoulder Innovations and its competitors. For the Medical Devices & Instruments industry, the median Days Payable is 68.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shoulder Innovations's current Days Payable is 144.60, which is 19% below median its own 10-year median of 178.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shoulder Innovations stock overvalued right now?
Shoulder Innovations (FRA:VB3) has a current Days Payable of 144.60. The current Days Payable is 144.60, which is 19% below median its 10-year median of 178.58 and 112% above the Medical Devices & Instruments industry median of 68.21. Shoulder Innovations' overall GF Score™ is 18/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shoulder Innovations (FRA:VB3), the current Days Payable is 144.60 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Shoulder Innovations Inc is a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market. It currently offers advanced implant systems for shoulder arthroplasty. Its products include: InSet Total Shoulder Arthroplasty; InSet Reverse Shoulder Arthroplasty; ProVoyance Shoulder Planning Software; and InSet Tray System. Geographically, the company operates in United States and are planning to expand.
18GF Score
Get the complete analysis for FRA:VB3
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:VB3 has been successfully added to your 
